Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Sponsor: First Hospital of China Medical University
Summary
This multicenter clinical study aims to build an intelligent and accurate diagnosis and dynamic prediction and early warning model of cardiotoxicity due to anthracycline-based breast cancer chemotherapy, clarify the value of the early warning model in guiding the targeted prevention of myocardial protection, providing an important theoretical basis for reducing the mortality rate of breast cancer and improving the prognosis.
Official title: Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy: a Prospective, Multicenter, Clinical Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2024-01-01
Completion Date
2028-12-31
Last Updated
2024-02-28
Healthy Volunteers
No
Conditions
Interventions
Echocardiography
Two-dimensional, color Doppler, spectral Doppler, tissue Doppler and three-dimensional echocardiographic image recordings will be taken using a Philips Epiq 7C echocardiography device and X5-1 probe. Conventional parameters, additional parameters, and strain analyzes will be performed by TomTec AutoStrain Suite Software
Locations (5)
Fujian Cancer Hospital
Fuzhou, Fujian, China
Dalian Friendship Hospital
Dalian, Liaoning, China
Dalian Municipal Central Hospital
Dalian, Liaoning, China
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
The Third People's Hospital Of Chengdu
Chengdu, Sichuan, China